This CR should net about 30M with all the options striking - an assumption but fair in the base case.
You’d THINK that with CT:VQ getting FDA approval, they would be able to reach reliable FCF with all these wins they’ve been accruing that will pay LT dividends.
Why the SP is continuing to stay below the SPP is beyond me signalling that the market believes the strap-on / piggy-back options are worth negative $$$.
Ann: 4DMedical gains regulatory approval for CT LVAS in Canada, page-22
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.010(4.00%) |
Mkt cap ! $111.7M | |||
| Open | High | Low | Value | Volume |
| 25.5¢ | 25.5¢ | 23.3¢ | $816.3K | 3.384M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 241659 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 161809 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| 4DX (ASX) Chart |